-
COVID-19 Federal Responses: Thursday, October 6, 2022
Noteworthy stories related to the pandemic are decreasing so this will be our last FEDERAL UPDATE. We will continue to keep membership advised of all the lates…
-
COVID-19 Federal Responses: Thursday, September 22, 2022
A new study found the bivalent Omicron booster triggered a strong antibody response against the Omicron variant after 28 days.
-
COVID-19 Federal Responses: Thursday, August 25, 2022
NIAID Director Dr. Anthony Fauci is optimistic the COVID-19 situation could be downgraded from pandemic to endemic before he retires at the end of the year.
-
COVID-19 Federal Responses: Thursday, August 18, 2022
By mid-September, updated COVID-19 booster shots, targeting BA.4 and BA.5 subvariants of the Omicron variant, will be available.
-
COVID-19 Federal Responses: Thursday, August 4, 2022
HHS is beginning to allow individual health care providers to order “Evusheld,” the new antibody therapy developed by AstraZeneca, for small patient groups of …
-
COVID-19 Federal Responses: Thursday, July 28, 2022
A CDC analysis found that immunocompromised patients accounted for 12.2% of all COVID-19-related hospitalizations.
-
COVID-19 Federal Responses: Thursday, July 21, 2022
COVID-19 nasal vaccines are still in early development stages, however health officials are optimistic that they could potentially prevent infections in the fu…
-
COVID-19 Federal Responses: Thursday, July 7, 2022
The FDA announced that it will allow state-licensed pharmacists to directly prescribe Paxlovid to COVID-19 patients.
-
COVID-19 Federal Responses: Thursday, June 30, 2022
CMS has announced that it will cover COVID-19 vaccinations for children 5 years old and younger who are covered through Medicare or CHIP.
-
COVID-19 Federal Responses: Thursday, June 23, 2022
A pediatrics study has revealed low vaccine efficacy towards the COVID-19 Omicron variant in teens with two vaccine doses, as opposed to teens who have receive…
-
COVID-19 Federal Responses: Thursday, June 16, 2022
The FDA’s Advisory Committee recommended the approval of Moderna’s COVID-19 vaccine for children under 5 years old
-
COVID-19 Federal Responses: Thursday, June 2, 2022
Data suggests that Omicron sub-variants are more immune-resistant than the original Omicron strain, possibly making retooled vaccines outdated by the time they…
-
COVID-19联邦反应:星期一day, May 23, 2022
The CDC now recommends that children between the ages of 5 and 11 receive a COVID-19 booster shot. This recommendation comes after the FDA authorized a boost…
-
COVID-19联邦反应:星期一day, May 16, 2022
美国国立卫生研究院已授权其稳定上升的蛋白质technology to the World Health Organization. The WHO will utilize the technology to help manufacturers worl…
-
COVID-19 Federal Responses: Thursday, May 5, 2022
New research about the cognitive impairment effects of long COVID-19 compares these symptoms to 20 years of cognitive aging and a reduction of 10 IQ points. …
-
COVID-19 Federal Responses: Thursday, April 21, 2022
Two variants of Omicron’s BA.2 sub lineage—BA.2.12 and BA.2.12.1—appear to spread about 25% faster than BA.2. The new variants are contagious enough that the…
-
COVID-19联邦反应:星期一day, April 18, 2022
The FDA granted emergency use authorization of a breath test that can detect COVID-19 infections within as little as three minutes and has a 0.7% rate of fal…
-
COVID-19 Federal Responses: Thursday, April 14, 2022
A statistical analysis of reported cases, hospital admissions, reported deaths, and seroprevalence estimates that 43.9% of the global population had been inf…
-
COVID-19联邦反应:星期一day, April 11, 2022
New research highlights the importance of air ventilation as a COVID-19 mitigation measure. Public health experts are tracking a new COVID-19 sub variant, l…
-
COVID-19联邦反应:星期一day, April 4, 2022
Increasing rates of norovirus infection are responsible for a wave of stomach flu. Cases are easily confused with COVID-19 as both can cause gastrointestinal…